Study record · Selank
Selank plus phenazepam versus phenazepam monotherapy in anxiety disorders
The combination arm was reported to improve aspects of anxiolytic treatment and tolerability.
Key result
The combination arm was reported to improve aspects of anxiolytic treatment and tolerability.
Study details
Study designComparative adjunct-treatment clinical study
PopulationPatients with anxiety-phobic, hypochondriac and somatoform disorders
Sample size70
RouteClinical Selank formulation
Regimen / exposurePhenazepam monotherapy n=30 versus Selank + phenazepam n=40
DurationClinical treatment course
ComparatorPhenazepam monotherapy
Primary endpoint / questionAnxiety, depression, CGI, Spielberger scales and tolerability
Safety resultNo large modern pharmacovigilance framework was established.
Key limitationsAdjunct design cannot isolate Selank's independent effect; older regional evidence.
Registry / identifierPMID 26356395